Skip to content

CVN MEDICAL

Active
Private limited companyfounded 2021active for 4 yearsRue Saint Lambert(WSP) 78, 1457 Walhain, BelgiumKBO/BCE: BE 0778.252.576
Summary

CVN MEDICAL has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €50,301 and a net result of €50,985. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 13% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 03-12-2021 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.324.835.028 1457 Walhain, since 03-12-2021
Financial year end
31 December
Peppol
Reachable since 24-11-2025

Board and ownership

Board
  • VAN NUFFELEN ChloéDirector

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€154,694
▲ 23.1%
Turnover
≈ €280,000
estimated
Profit
€50,985
▲ 27.6%
Equity
€50,301
▲ 345%
Total assets
€552,992
▼ 9.6%
Employees on 31-12-2025
1
=
Score breakdownraises riskEquity €50,301 (9.1% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €552,992Figures for financial year 2025 (filed on 27-04-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 42% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 34+7
equity 9.1% of total assets
Liquidity 56+4
short-term debt 10.4% · cash 5.1%
Profitability 80+12
return on assets 9.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.1%highest value 01-2025: 0.1%● unchanged vs 12-2024highest value 02-2025: < 0.1%▼ -0.1 percentage points vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €4,500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.79 (0.65 in 2024), below 1. Short-term debt is 10.4% and cash 5.1% of total assets. 90.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 14% of them on solvency, 32% on liquidity, 27% on profitability and 97% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €552,992
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 27-04-2026)
NBB · annual accounts
raises risk · Equity €50,301 (9.1% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 13%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-04-2026, 98 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
98 days early
2024
57 days early
2023
49 days early
2022
45 days early
2021
11 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 52 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 June (4 of the last 5 accounts filed within 37 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 86% of companies in human healthsector median 63.0% · 20,700 companies 9.1% View
  • Positive: Always filed on timeaccounts within the deadline every year 5 years View

Recent changes

  1. · Gazette deed Registered office moved from Namur to Walhain
  2. · Gazette deed Incorporation
All 9 events

Comparable companies

These companies have the same main activity as CVN MEDICAL: general medical practice (NACE 86210). They are comparable in size and age: total assets between €474,000 and €644,000, founded between 2020 and 2022.

CompanyTotal assetsGross margin
CVN MEDICAL Walhain€552,992€154,694
MEDINIS Braine-le-Château€644,007€160,616
Dr. Nathalie De Maeyer Boom€563,574€164,182
Dokter Mohamed Ghazal Antwerpen€525,138€145,390
Dr. Paquay Elisa Peer€561,223€160,747
DOKTER LORE VERSTRAETE Roeselare€474,088€161,681
Médi-Engis Engis€537,262€150,886
Full comparison

Key facts about CVN MEDICAL

What is the company number of CVN MEDICAL?
The company number of CVN MEDICAL is 0778.252.576. The VAT number is the same number with BE in front: BE 0778.252.576.
Where is CVN MEDICAL based?
The registered office is at Rue Saint Lambert(WSP) 78, 1457 Walhain.Company details
What does CVN MEDICAL do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of CVN MEDICAL?
The legal form of CVN MEDICAL is Private limited company (BV).
When was CVN MEDICAL founded?
CVN MEDICAL was founded on 03-12-2021.
Is CVN MEDICAL still active?
Yes, CVN MEDICAL is an active enterprise in the KBO register.
How many employees does CVN MEDICAL have?
CVN MEDICAL had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of CVN MEDICAL?
The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €154,694 and 30 comparable companies (NACE 86210). It probably lies between €220,000 and €350,000.
Is CVN MEDICAL profitable?
In financial year 2025, CVN MEDICAL made a profit of €50,985.
Where can I find the annual accounts of CVN MEDICAL?
CVN MEDICAL filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CVN MEDICAL due?
CVN MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.